このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effect of Front-of-Package Labels on Intent to Purchase Packaged Foods in the Philippines

Effect of Front-of-Package Labels on the Intent to Purchase Packaged Foods in the Philippines: A Five-Arm Randomized Controlled Trial

The Philippines is considering a mandatory front-of-package label (FoPL) for packaged foods. This randomized controlled trial will test which label design best helps consumers avoid products high in sugar, sodium, or saturated fat. Adults who buy packaged foods will be approached outside supermarkets and other food retailers in three locations: the City of Manila, Iloilo City, and the Municipality of San Jose, Dinagat Islands. After consent, each participant will be randomly assigned to one of five groups and will view mock packaged food products on a tablet: no label (control), a Nutrient Warning Label, a Multiple Traffic Light label, a Health Star Rating, or a Nutri-Grade style label. The main outcome is how likely participants say the participant is to buy products that contain nutrients of concern in excess. The study will also measure whether participants can correctly identify which nutrients are in excess, which of two similar products the participant would buy, and which product the participant thinks is healthier. Results will inform FoPL policy in the Philippines.

調査の概要

状態

募集

条件

介入・治療

詳細な説明

This is a five-arm, parallel-group, individually randomized trial with a single study visit of about 25 minutes. Trained research assistants recruit participants using street-intercept methods outside food retailers, screen for eligibility, and obtain written informed consent. Participants are randomized 1:1:1:1:1 in REDCap, stratified by study site, using an allocation table generated by an independent statistician; the enumerator does not know the allocation sequence in advance.

Within the assigned arm, participants complete: (1) single-product tasks, in which the participant views one mock product at a time (product order randomized), rate the intent to purchase on a 7-point scale, and indicate whether the product contains sugar, sodium, saturated fat, or protein in excess (protein is a distractor and is never in excess); (2) paired-product comparison tasks, in which, for three pairs of similar products showing different versions of the same label system, the participant's choose which product the participant would buy, which is healthier, and which the participant would be more worried about a child consuming; and (3) label acceptability questions, a label comparison task, and demographic questions. The Pan American Health Organization (PAHO) Nutrient Profile Model is used as an independent standard to classify products as containing sugar, sodium, or saturated fat in excess.

Sample size: 2,105 participants (approximately 701 per site; 421 per arm). This provides 80% power to detect a 0.36-point difference in mean intent to purchase (SD 1.5) for each label versus no label (Bonferroni alpha = 0.0125) and for pairwise comparisons among effective labels (alpha = 0.0083).

Primary analysis: a linear model of each participant's mean purchase-intent score across four products, with treatment arm as a fixed effect and no label as the reference category (four primary contrasts), adjusting for pre-specified baseline covariates that are imbalanced across arms. Multiplicity is controlled using the Hochberg step-down procedure. If any label is effective compared with no label, effective labels are compared pairwise (up to six contrasts). Statisticians are blinded to arm assignment for the primary outcome analysis.

研究の種類

介入

入学 (推定)

2105

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Dinagat Islands
      • San Jose、Dinagat Islands、フィリピン
        • まだ募集していません
        • Municipality of San Jose, Dinagat Islands
    • Iloilo
      • Iloilo City、Iloilo、フィリピン
        • まだ募集していません
        • Iloilo City
    • National Capital Region
      • Manila、National Capital Region、フィリピン
        • 募集
        • City of Manila

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~59年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Age 18 to 59 years
  • Purchases packaged foods
  • Resident of the Philippines
  • Able and willing to provide written informed consent

Exclusion Criteria:

  • Age under 18 or over 59 years
  • Does not purchase packaged foods
  • Not a resident of the Philippines
  • Adults lacking capacity to consent

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
介入なし:No label (control)

Participants view mock packaged food products without any front-of-package label.

実験的:Nutrient Warning Label (NWL)

Mock packaged food products display black octagonal warning labels for each nutrient (sugar, sodium, saturated fat) present in excess.

Front-of-package warning symbols flagging each nutrient of concern (sugar, sodium, saturated fat) that exceeds the label's nutrient profile threshold, applied to mock packaged food images shown on a tablet during a single study visit.

他の名前:
  • NWL
実験的:Multiple Traffic Light (MTL)

Mock packaged food products display a Multiple Traffic Light label with red, amber, or green color coding of sugar, sodium, and saturated fat levels.

Front-of-package label showing levels of sugar, sodium, and saturated fat color-coded red, amber, or green, applied to mock packaged food images shown on a tablet during a single study visit.

他の名前:
  • MTL
実験的:Health Star Rating (HSR)

Mock packaged food products display a Health Star Rating summary score (0.5 to 5 stars).

Front-of-package summary rating from 0.5 to 5 stars based on an underlying nutrient profile algorithm, applied to mock packaged food images shown on a tablet during a single study visit.

他の名前:
  • 高速鉄道
実験的:Nutri-Grade style (NG)

Mock packaged food products display a Nutri-Grade style letter-grade label.

Front-of-package letter-grade summary label (Nutri-Grade style), applied to mock packaged food images shown on a tablet during a single study visit.

他の名前:
  • NG

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Mean Self-Reported Intent to Purchase Products Containing Nutrients of Concern in Excess
時間枠:During the single study visit (Day 1, approximately 25 minutes)

After viewing each of four mock packaged products containing sugar, sodium, and/or saturated fat in excess (per the PAHO Nutrient Profile Model), participants answer: "Imagine you were looking to buy [product]. Would you buy this product for yourself or your family?" on a fully labeled 7-point scale (1 = I would certainly not buy this product; 4 = Neutral; 7 = I would definitely buy this product). The outcome is the participant's mean score across the four products (range 1-7; higher scores indicate greater intent to purchase). Each front-of-package label arm is compared with the no-label control.

During the single study visit (Day 1, approximately 25 minutes)

二次結果の測定

結果測定
メジャーの説明
時間枠
Accuracy in Identifying Nutrients of Concern Present in Excess
時間枠:During the single study visit (Day 1)

For each single-product task, participants report whether the product contains sugar, sodium, saturated fat, and protein in excess (Yes / No / I don't know). Reported as the proportion of correct identifications (sensitivity and overall accuracy) per nutrient and pooled across products, compared between each label arm and no label and among effective labels. "I don't know" is counted as incorrect. Protein is never in excess; the false-positive rate for protein is also reported.

During the single study visit (Day 1)
Selection of the Healthier Product for Purchase in Paired Product Comparisons
時間枠:During the single study visit (Day 1)

For each of three pairs of similar products showing different versions of the assigned label system (e.g., fewer vs. more warnings), participants choose which product the participant would buy (Product A / Product B / Either / Neither). Outcome: selection of the healthier product (1) vs. any other response (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

During the single study visit (Day 1)
Correct Identification of the Healthier Product in Paired Product Comparisons
時間枠:During the single study visit (Day 1)

For each of three product pairs, participants choose which product is healthier (Product A / Product B / I don't know). Outcome: correct choice (1) vs. incorrect choice or "I don't know" (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

During the single study visit (Day 1)
Concern About Child Consumption in Paired Product Comparisons (proportion of participants selecting the less healthful product)
時間枠:During the single study visit (Day 1)

For each of three product pairs, participants choose which product the participant would be more worried about letting a child consume (Product A / Product B / I don't know). Reported as the proportion selecting the less healthful product, by arm.

During the single study visit (Day 1)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

協力者

捜査官

  • 主任研究者:Megan E Henry, PhD、Johns Hopkins Bloomberg School of Public Health
  • 主任研究者:TJ Robinson Moncatar, RN, MPH, PhD、University of the Philippines Manila, College of Public Health

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年11月15日

一次修了 (推定)

2026年12月1日

研究の完了 (推定)

2027年6月1日

試験登録日

最初に提出

2026年11月16日

QC基準を満たした最初の提出物

2026年11月16日

最初の投稿 (実際)

2026年11月20日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月20日

QC基準を満たした最後の更新が送信されました

2026年11月16日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • IRB00033681
  • 90104337 (その他の助成金/資金番号:Resolve to Save Lives)
  • UPMREB 2026-0392-01 (その他の識別子:University of the Philippines Manila Research Ethics Board)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Under the Institutional Review Board (IRB) approved data management plan, individual participant data will not be shared with investigators outside the study team.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。